SLC9A1 and cardiac hypertrophy: This is followed by assessment ofthe role of NHE1 in cardiac pathologies including ischemic and reperfusioninjury, myocardial hypertrophy and remodeling resulting in heart failure as wellas its role in diabetes related cardiac pathology.